WallStreetZenWallStreetZen

NASDAQ: DAWN
Day One Biopharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Day One Biopharmaceuticals revenue was $158.18M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $53.7M, up 35% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DAWN annual revenue was $158.2M, with 20.6% growth year-over-year.

DAWN past revenue growth

How has DAWN's revenue growth performed historically?

Company
20.6%
Industry
469.74%
Market
90.22%
DAWN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DAWN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DAWN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DAWN revenue history

Current Revenue
$158.2M
Current Earnings
-$107.3M
Current Profit Margin
-67.8%

Be the first to know when DAWN announces revenue.

DAWN Revenue History By Year

DAWN Yearly RevenueDAWN RevenueDAWN ChangeDAWN Revenue Growth
2025-12-31$158.18M$27.02M+20.60%
2024-12-31$131.16MN/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Day One Biopharmaceuticals Revenue FAQ

What was DAWN's revenue last quarter?

On Invalid Date, Day One Biopharmaceuticals (NASDAQ: DAWN) reported Q4 2025 revenue of $53.72 million up 83.92% year over year. In the same quarter last year, Day One Biopharmaceuticals's revenue was $29.21 million.

What was Day One Biopharmaceuticals's revenue in 2025?

Day One Biopharmaceuticals's annual revenue for the twelve months ending Dec 31, 2025 was $158.18 million, a 20.6% increase year over year.

How much does Day One Biopharmaceuticals make in a day?

Based on Day One Biopharmaceuticals annual revenue for the past five years, DAWN makes an average of $158,544.11 per day.

What was Day One Biopharmaceuticals's annual revenue growth in the past year?

As of Q1 2026, Day One Biopharmaceuticals's revenue has grown 20.6% year over year. This is 449.14 percentage points lower than the US Biotechnology industry revenue growth rate of 469.74%. Day One Biopharmaceuticals's revenue in the past year totaled $158.18 million.

How much does Day One Biopharmaceuticals make in a year?

Day One Biopharmaceuticals's revenue by year for the past five years is:
  • Day One Biopharmaceuticals's revenue for the twelve months ending Dec 31, 2025 was $158.18 million, a 20.6% increase year over year.
  • Day One Biopharmaceuticals's annual revenue for Dec 31, 2024 was $131.16 million, a Infinity% increase from 2023.
  • Day One Biopharmaceuticals's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
  • Day One Biopharmaceuticals's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Day One Biopharmaceuticals's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.